Increased progesterone receptor expression in uterine leiomyoma: correlation with age, number of leiomyomas, and clinical symptoms.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Fertility and Sterility

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.fertnstert.2015.04.024PMID 26006736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uterine fibroids

  2017influential reference
• Role of nuclear progesterone receptor isoforms in uterine pathophysiology.

  2015cited by this paper
• Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

  2015cited by this paper
• Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.

  2014cited by this paper
• Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.

  2014cited by this paper
• Uterine leiomyoma: available medical treatments and new possible therapeutic options.

  2013cited by this paper
• Uterine fibroids.

  2013cited by this paper
• Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

  2013cited by this paper
• Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction

  2013cited by this paper
• High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation.

  2013cited by this paper
• The endocrine and paracrine control of menstruation.

  2012cited by this paper
• Emerging indications for the levonorgestrel‐releasing intrauterine system (LNG‐IUS)

  2012cited by this paper
• The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

  2012cited by this paper
• Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3.

  2011cited by this paper
• Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications.

  2011cited by this paper
• Progesterone is essential for maintenance and growth of uterine leiomyoma.

  2010cited by this paper
• Progesterone and ovulation across stages of the transition to menopause

  2009cited by this paper
• Sex steroidal modulation of collagen metabolism in uterine leiomyomas.

  2009cited by this paper
• Growth of uterine leiomyomata among premenopausal black and white women

  2009cited by this paper
• Growth of uterine leiomyomata among premenopausal black and white women

  2008cited by this paper
• Comparative Effects of SPRM Asoprisnil (J867) on Proliferation, Apoptosis, and the Expression of Growth Factors in Cultured Uterine Leiomyoma Cells and Normal Myometrial Cells

  2007cited by this paper
• Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation.

  2007cited by this paper
• Understanding the Perimenopause

  2007cited by this paper
• Role, Epidemiology, and Natural History of Benign Uterine Mass Lesions

  2005cited by this paper
• Uterine Fibroids: The Elephant in the Room

  2005cited by this paper
• Sex steroidal regulation of uterine leiomyoma growth and apoptosis.

  2004cited by this paper
• A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use

  2003cited by this paper
• Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.

  1999cited by this paper
• Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium.

  1997cited by this paper
• A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.

  1996cited by this paper
• Characterization of reproductive hormonal dynamics in the perimenopause.

  1996cited by this paper
• A Simple Visual Assessment Technique to Discriminate Between Menorrhagia and Normal Menstrual Blood Loss

  1995cited by this paper
• Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas.

  1993cited by this paper
• The frequency of uterine leiomyomas.

  1990cited by this paper
• Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.

  1990cited by this paper
• Size and Weight Determinations of Nongravid Enlarged Uteri

  1986cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Sex Steroid Receptors in Human Myometrium and Fibroids: Changes during the Menstrual Cycle and Gonadotropin-Releasing Hormone Treatment*

  year unknowncited by this paper

• Gutartige Tumoren des Uterus

  2026cites this paper
• Comparative Analysis of Differentially Expressed Long Non-Coding RNA in Pre- and Postmenopausal Fibroids

  2025cites this paper
• Tailoring the Diagnostic Pathway for Medical and Surgical Treatment of Uterine Fibroids: A Narrative Review

  2024cites this paper
• Gene Expression Profile of Uterine Leiomyoma from Women Exposed to Different Air Pollution Levels in Metropolitan Cities of Sao Paulo, Brazil

  2023cites this paper
• Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case

  2022cites this paper
• Ulipristal Acetate (UPA): An Alternative Option to Surgery for Uterine Fibroids in Reproductive Age: A Review

  2022cites this paper
• Uterine myoma is associated with an increased risk of lung cancer: A nationwide population‐based cohort study

  2021cites this paper
• Gutartige Tumoren des Uterus

  2021cites this paper
• Possibilities of drug therapy for uterine leiomyoma in reproductive age

  2021cites this paper
• Progesterone Receptor and Uterine Myomas Growth

  2021cites this paper
• Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids

  2021cites this paper
• Peranan Resveratrol terhadap Progresivitas Uterine Fibroid

  2021cites this paper
• Genetic and Epidemiological Similarities, and Differences Between Postoperative Intraperitoneal Adhesion Development and Other Benign Fibro-proliferative Disorders

  2021cites this paper
• Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review

  2020cites this paper
• Updates of Uterine Fibroid Management

  2020cites this paper
• Non-surgical treatment of uterine fibroids. Efficacy of the selective progesterone receptor modulator

  2019cites this paper
• Uterine Fibroids and Infertility

  2019cites this paper
• The influence of the expression of steroid receptors on angiogenesis, proliferation and apoptosis in myomas of pre- and postmenopausal women

  2019cites this paper
• Prior uterine myoma and risk of ovarian cancer: a population-based case-control study

  2019cites this paper
• Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study.

  2019cites this paper
• Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.

  2018cites this paper
• Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.

  2018cites this paper
• A mouse model engineered to conditionally express the progesterone receptor‐B isoform

  2018cites this paper
• Uterine fibroids and risk of hypertension: Implication of inflammation and a possible role of the renin‐angiotensin‐aldosterone system

  2018cites this paper
• Current conservative treatment of uterine fibroids. Ulipristal acetate and liver damage: contrived tragedy?

  2018cites this paper
• What Is the Place of Myoma Surgery with the Advent of Selective Progesterone Receptor Modulators (SPRMs)

  2018cites this paper
• Current medical treatment of uterine fibroids

  2018cites this paper
• Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation

  2017cites this paper
• Analyse der Funktionalität von Hormonrezeptoren und der HOXA10-Expression endometrialer Stromazellen zur Ursachenforschung bei Patientinnen mit MRKH-Syndrom

  2017cites this paper
• Med12 regulates ovarian steroidogenesis, uterine development and maternal effects in the mammalian egg †

  2017cites this paper
• Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms

  2017cites this paper
• Epidemiology and Risk Factors of Uterine Fibroids.

  2017cites this paper
• Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells

  2017cites this paper
• Developmental Exposure to Endocrine Disruptors Expands Murine Myometrial Stem Cell Compartment as a Prerequisite to Leiomyoma Tumorigenesis

  2017cites this paper
• The current place of medical therapy in uterine fibroid management.

  2017cites this paper
• Molecular mechanisms of regulation of uterine leiomyoma growth

  2017influential citation
• Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids

  2017cites this paper
• The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids.

  2017cites this paper
• Nonsurgical Alternatives for Uterine Fibroids.

  2016cites this paper
• Empowering organ-preserving treatment of uterine fibroids using ulipristal acetate

  2016cites this paper
• Endocrine-disrupting chemicals and uterine fibroids.

  2016cites this paper
• Ovarian down Regulation by GnRF Vaccination Decreases Reproductive Tract Tumour Size in Female White and Greater One-Horned Rhinoceroses

  2016cites this paper
• Hormones and pathogenesis of uterine fibroids.

  2016cites this paper
• Role of Medical Management for Uterine Leiomyomas.

  2016cites this paper
• Uterine fibroid management: from the present to the future

  2016cites this paper
• Differential expression of estrogen receptor α and β isoforms in multiple and solitary leiomyomas.

  2015cites this paper
• Current management of myomas: the place of medical therapy with the advent of selective progesterone receptor modulators

  2015cites this paper
• Medikamentöse Myomtherapie

  2015cites this paper